Annie Hai-yuan Lo Elected to Quintiles Transnational Holdings Inc. Board of...
RESEARCH TRIANGLE PARK, N.C. Quintiles Transnational Holdings Inc. (“Quintiles” or the “Company”) (NYSE: Q) announced today that Annie Hai-yuan Lo, has been appointed to its Board of Directors,...
View Article武田药品用于治疗多发性硬化症的药物Copaxone® 20毫克皮下针剂的新药申请在日本获得核准
日本大阪 (美国商业资讯) — 武田药品工业株式会社(TOKYO:4502)的多发性硬化症治疗药物Copaxone® 20毫克皮下针剂(通用名:glatiramer acetate)的新药申请今天获得日本厚生劳动省的核准。 Copaxone® 由Teva Pharmaceutical Industries Ltd....
View Article50+ Forensic DNA Experts to Present at the 2015 International Symposium on...
MADISON, Wis. Learn from forensic luminaries, who will share their experiences solving crimes, deciphering historical mysteries and advancing the fields of forensics and DNA analysis, at the...
View ArticleFrontage Doubles Bioanalytical Lab Capacity in USA Due to Increased Demand...
EXTON, Pa. Frontage, a full service contract research organization (CRO) located in the USA and China, is pleased to announce the expansion of its bioanalytical laboratories to meet increased demand...
View Article‘The First Giant Salamander Industry Development & Technology Forum’ Was...
ZHANGJIAJIE, China The First Giant Salamander Industry Development & Technology Forum’ was grandly held at Zhangjiajie Grand Metro Park Resort by Zhangjiajie Municipal Government (The Host) and...
View ArticleBard Agrees to Acquire Full Ownership of its Joint Venture in Japan
MURRAY HILL, N.J. C. R. Bard, Inc. (NYSE:BCR) announced today that it has entered into a definitive agreement to acquire Kobayashi Pharmaceutical Co., Ltd.’s (Kobayashi) 50% ownership share in...
View ArticleNovati Technologies Launches Industry’s Most Advanced Integrated Sensor Platform
DRESDEN, Germany Novati Technologies Inc., a leading global nanotechnology development center, today announced the availability of the industry’s most advanced Integrated Sensor Platform, placing a...
View ArticleTransgenomic Signs Binding Term Sheet to Divest Genetic Assays & Platforms...
OMAHA, Neb. Transgenomic, Inc. (NASDAQ: TBIO) today announced that it has entered into a definitive and binding term sheet to divest its Genetic Assays & Platforms (GAP) Business Unit to ADSTEC...
View ArticleAmoy Diagnostics and Illumina Enter Strategic Collaboration for...
XIAMEN, China & SAN DIEGO Amoy Diagnostics Co. Ltd. (ADx) and Illumina, Inc. (NASDAQ: ILMN) today announced a strategic collaboration to accelerate the adoption of precision medicine and...
View Article昆泰连续第三年获评IV期服务领导者
北卡罗莱纳州研究三角园区 (美国商业资讯)–来自于行业标准研究(Industry Standard Research, ISR)的2015年度 CRO品质标准 – IV期服务提供商报告已连续第三年将昆泰评选为IV期服务的市场领导者。...
View ArticleAnnie Hai-yuan Lo入选昆泰董事会
北卡罗莱纳州研究三角园区 (美国商业资讯)–Quintiles Transnational Holdings Inc.(下称“昆泰”或“公司”)(NYSE: Q)今天宣布,Annie Hai-yuan Lo已被任命为其董事会成员,即刻生效。Lo女士还将成为董事会审计委员会成员。 Smart News Releases(智能新闻稿)是一个多媒体平台。在此处查看完整新闻稿:...
View Articleクインタイルズが3年連続で第IV相サービスのリーダー企業として評価される
米ノースカロライナ州リサーチ・トライアングル・パーク (ビジネスワイヤ) — クインタイルズはインダストリー・スタンダード・リサーチ(ISR)の2015年CROクオリティーベンチマーキング – 第 IV相サービスプロバイダー報告書(CRO Quality Benchmarking – Phase IV Service Providers...
View ArticleAnnie Hai-yuan Loをクインタイルズ・トランスナショナル・ホールディングスの取締役に選任
米ノースカロライナ州リサーチ・トライアングル・パーク (ビジネスワイヤ)–クインタイルズ・トランスナショナル・ホールディングス(以降「クインタイルズ」または「当社」)(NYSE: Q)は本日、Annie Hai-yuan Loを本日付で当社取締役に任命したと発表しました。またLoは、取締役会の監査委員会にも加わります。 このSmart News...
View ArticleMorinaga’s Flagship Probiotic Strain BB536 Is Now 100% Gluten-Free
TOKYO Morinaga Milk Industry Co., Ltd. (TOKYO:2264), the second-largest dairy product company in Japan, announced today that it has completely eliminated gluten from its flagship product, the...
View Articleロンドン市長とメドシティがBioJapanで細胞治療キャンペーンをスタート:2015年10月14日
ロンドン&横浜、日本 時下益々ご清栄のこととお喜び申し上げます。 ロンドン市長のボリス・ジョンソンMPとメドシティは、BioJapan2015にて細胞治療と再生医療における日英のコラボレーションを振興する、新規大型キャンペーンを立ち上げます。 BioJapanへの訪問は、ロンドン市長の3日間にわたる貿易視察の一環です。...
View ArticleCompany Profile for Chugai Pharmaceutical Co., Ltd.
Chugai Pharmaceutical (TOKYO:4519) is one of Japan’s leading research-based pharmaceutical companies with strengths in biotechnology products. Chugai, based in Tokyo, specializes in prescription...
View Article取り消し October 2, 2015 ロンドン市長とメドシティがBioJapanで細胞治療キャンペーンをスタート:2015年10月14日
取り消し October 2, 2015 ロンドン市長とメドシティがBioJapanで細胞治療キャンペーンをスタート:2015年10月14日 businesswire.comでソースバージョンを見る:http://www.businesswire.com/news/home/20151001005730/ja/ CONTACT London & PartnersAbigail...
View ArticleArcadia Biosciences Receives US Patent for Resistant Starch Wheat Technology
DAVIS, Calif. Arcadia Biosciences, Inc. (NASDAQ:RKDA), an agricultural technology company, announced that the United States Patent and Trademark Office has granted the company US Patent No....
View ArticleFeld Entertainment和Primary Children’s Hospital发布新的癌症研究筹款计划
佛罗里达州埃伦顿 (美国商业资讯)–Feld Entertainment, Inc.( Ringling Bros. and Barnum & Bailey® 和Ringling Bros. Center for Elephant Conservation®的母公司)的权属人Feld家族今天宣布,将与Intermountain Primary Children’s Hospital...
View Article